Metastatic or Unresectable Solid Tumors
1 clinical trials · Condition
◉ Watch Metastatic or Unresectable Solid Tumors
| Record | Firm | Date |
|---|---|---|
| STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors (NCT00088101) | Synta Pharmaceuticals Corp. | 2004-02-01 |
Track Metastatic or Unresectable Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.